CA Patent

CA3001337A1 — Pharmaceutical formulation

Assigned to RB Health US LLC · Expires 2017-04-13 · 9y expired

What this patent protects

A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours.

USPTO Abstract

A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours.

Drugs covered by this patent

Patent Metadata

Patent number
CA3001337A1
Jurisdiction
CA
Classification
—
Expires
2017-04-13
Drug substance claim
No
Drug product claim
No
Assignee
RB Health US LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.